Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation. (Q51789305)

12 April 2018

title

Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation. (English)

1 reference

12 April 2018

author name string

Gulshan Ara

1

1 reference

12 April 2018

Brynmor A Watkins

2

1 reference

12 April 2018

Haihong Zhong

3

1 reference

12 April 2018

Thomas R Hawthorne

4

1 reference

12 April 2018

Cyrus E Karkaria

5

1 reference

12 April 2018

Stephen T Sonis

6

1 reference

12 April 2018

William J Larochelle

7

1 reference

12 April 2018

publication date

1 May 2008

1 reference

12 April 2018

International Journal of Radiation Biology

published in

1 reference

12 April 2018

volume

84

1 reference

12 April 2018

issue

5

1 reference

12 April 2018

page(s)

401-412

1 reference

12 April 2018

Ionizing radiation induces expression and binding activity of the nuclear factor kappa B

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Effect of granulocyte macrophage-colony stimulating factor (GM-CSF) on 5-FU-induced ulcerative mucositis in hamster buccal pouches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Acute radiation effects in normal tissues--translational aspects of biological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Radiation-induced changes in cellularity and proliferation in human oral mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Effects of ceramide inhibition on experimental radiation-induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Evolution of the Fgf and Fgfr gene families

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

A novel human fibroblast growth factor treats experimental intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Updated clinical practice guidelines for the prevention and treatment of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Chemotherapy-induced oral mucositis. Prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Amifostine in clinical oncology: current use and future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

An important role of Nrf2-ARE pathway in the cellular defense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Human fibroblast growth factor 20 (FGF-20; CG53135-05): a novel cytoprotectant with radioprotective potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Research advances in oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Fibroblast growth factors, their receptors and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Palifermin for oral mucositis after intensive therapy for hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Fibroblast growth factors as multifunctional signaling factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000802007601

10.1080/09553000802007601

21 January 2018

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

18464069

1 reference

12 April 2018